Zobrazeno 71 - 80
of 84
pro vyhledávání: '"329"'
Autor:
Lidia Mongay, John V. Reynolds, Hagop M. Kantarjian, David Joske, Luis Meillon, Jorge E. Cortes, Dong-Wook Kim, Ricardo Pasquini, Timothy P. Hughes
Publikováno v:
ResearcherID
Abstract 2292 Background: This ongoing international, prospective registry provides 5-year longitudinal data on diagnosis methods, management strategies, and outcomes for CML patients (pts) worldwide. Deviations from published disease management reco
Autor:
James L.M. Ferrara, Jochen Metzger, Arnold Ganser, Annika Krons, Hildegard T. Greinix, Ernst Holler, Gernot Beutel, Julia Kontsendorn, Michael Schleuning, Stefanie Buchholz, Anne M. Dickinson, N. Hahn, Hans-Jochem Kolb, Axel R. Zander, Eva Mischak-Weissinger
Publikováno v:
Blood. 114:347-347
Abstract 347 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for many hematologic malignancies or hematopoietic dysfunction syndromes, but the application is still limited due to major complications, such as sev
Autor:
Jana Markova, Andreas Engert, Richard Herrmann, Peter Borchmann, Rolf P. Mueller, Bernd Doerken, Michael Fuchs, Annette Pluetschow, Hans Konrad Mueller-Hermelink, Hans Theodor Eich, Volker Diehl, Lothar Kanz, Richard Greil
Publikováno v:
Blood. 114:716-716
Abstract 716 Background: There has been an ongoing debate on the best treatment for patients with early favourable Hodgkin lymphoma (HL). Open questions include the choice between combined modality treatment or chemotherapy only, the number of chemot
Autor:
Kai Neben, Bernard Klein, Uta Bertsch, Dirk Hose, Jérôme Moreaux, Hartmut Goldschmidt, Anna Jauch, Christoph Schultes, Tobias Meiβner, Joe Lewis, Christof von Kalle, Jens Hillengass, Jürgen Zimmermann, Jean François Rossi, Vladimir Benes, Thomas Möhler, Anja Seckinger, Blanka Rebacz
Publikováno v:
Blood. 114:2856-2856
Abstract 2856 Poster Board II-832 BACKGROUND. Molecular profiling of multiple myeloma allows the identification of novel targets, including HIF1A, and evaluation of their expression within large cohorts of patients. We report here the expression of H
Autor:
John A. Liu Yin, Lars Kjeldsen, Robert Kerrin Hills, Brenda Gibson, Alan Kenneth Burnett, Donald Milligan, Ann Hunter, Archie G. Prentice, Anthony H. Goldstone, Keith Wheatley, Nigel H. Russell
Publikováno v:
Blood. 114:484-484
Abstract 484 On behalf of the NCRI AML Working Group, United Kingdom There is a general acceptance that survival in younger patients (75% relapse remains a problem. Optimisation of induction and defining the schedule and duration of post-induction ch
Autor:
Nelly Nancy Safaian, Ingmar Bruns, Guido Kobbe, Christian Saure, Thomas Schroeder, Roland Fenk, Akos Czibere, Rainer Haas, Fabian Zohren
Publikováno v:
Blood. 114:2057-2057
Abstract 2057 Poster Board II-34 Introduction: Patients with acute myeloid leukemia (AML) and activating mutations in the Fms-like tyrosine-3 (FLT3) gene have an abysmal prognosis. Together with other groups we have recently demonstrated the clinical
Autor:
Andrea Bacigalupo, Gérard Socié, Meral Beksac, Nigel H. Russell, Birte Friedrichs, Norbert Schmitz, Tapani Ruutu, Andre Tichelli
Publikováno v:
Blood. 112:451-451
In 2002, the EBMT reported on the largest prospective randomized study comparing filgrastim-mobilized peripheral blood progenitor cell (PBPC) to bone marrow (BM) transplantation (Schmitz et al. Blood 2002). Patient accrual took place between 02/95 an
Autor:
Chatchada Karanes, Tang-Her Jaing, Stephen J. Forman, M. Graham, Ah Moy Tan, Patrick Tan, Brian Wang, Gretchen Eames, Auayporn Nademanee, Joseph Rosenthal, Hai Peng Lin, Lawrence Petz, David W. Gjertson, Tiffany Chow, Lee Lee Chan, Robert Chow, Tina Wu
Publikováno v:
Blood. 112:4406-4406
Unrelated cord blood (UCB) is an important stem cell source for unrelated hematopoietic cell transplantation of patients with non-malignant disorders. Cell dosage is a critical factor for successful UCB hematopoietic stem cell transplantation (HSCT).
Autor:
Vanessa Moreno B, Arantxa García-Raso, Raquel Mata, Dolores Subirá, Maria Jose Garcia-Bueno, José Luis Martínez, Pilar Llamas, Carmen Maxi Rodríguez Sánchez
Publikováno v:
Blood. 108:4094-4094
Ischemic cerebrovascular disease (ICD) is a multi-factorial entity whose anatomopathologic substrate is atherosclerosis. The inflammatory cells migrate to vascular endothelium and release chemokines such as interleukin 6 (IL6), resulting in the ather
Autor:
Susana Perdomo, Cecilia Guillermo, Lilián Díaz, Martha Nese, Alberto Baubeta, Laura Topolansky, Andrea Diaz, Mariana Stevenazzi, Ana Perdomo, Hugo Isaurralde, Graciela Lavagna, Juan Zunino
Publikováno v:
Blood. 108:5430-5430
Between 1995 and 2005, we performed 329 hematopoietic stem cell transplantation (HSCT), 286 autoulogous and 43 allogeneic. Long term results of treatment and outcome of ASCT in 100 Non Hodgkin Lymphoma (NHL) were analyzed. Median age was 47 years (ra